HUTCHMED DRC (HCM)

HUTCHMED DRC (HCM) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.5B; returns 1 day +0.6%, 1 week +2.2%, 1 year -4.5%.

HUTCHMED (China) Limited, headquartered in Hong Kong, is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative therapeutics and immunotherapies for cancer and immunological diseases. It operates through an integrated model encompassing early discovery research, clinical development, regulatory filings, and commercial launches.

Groups HCM belongs to

• Healthcare
• Biopharmaceutical
• Biotechnology
• Oncology
• Pharmaceuticals
• Commercial Stage Biotech
• China Healthcare
• Immunotherapy
• Life Sciences
• China Market
• Hong Kong
• Autoimmune Diseases

HCM financial model: income statement, cash flow and balance sheet